New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
04:55 EDTBOTA, BOTA, BOTA, BOTA, IMGN, IMGN, IMGN, IMGN, ARRY, ARRY, ARRY, ARRY, OFIX, OFIX, OFIX, OFIX, CMN, CMN, CMN, CMN, MDCO, MDCO, MDCO, MDCO, TTHI, TTHI, TTHI, TTHI, INO, INO, INO, INO, CNAT, CNAT, CNAT, CNAT, Q, Q, Q, QJefferies to hold a conference
2014 Global Healthcare Conference to be held in New York on June 2-5.
News For BOTA;CNAT;INO;TTHI;MDCO;CMN;OFIX;ARRY;IMGN;Q From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 20, 2014
08:03 EDTINOInovio's melanoma immunotherapy shows positive preclinical survival results
Subscribe for More Information
07:41 EDTMDCOThe Medicines Co. upgraded at Credit Suisse
Subscribe for More Information
06:13 EDTTTHITransition Therapeutic announces results from study of Down syndrome candidate
Subscribe for More Information
06:06 EDTMDCOThe Medicines Co. upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
November 18, 2014
13:16 EDTCMNCantel Medical management to meet with Sidoti
Meeting to be held on New York on November 20 hosted by Sidoti.
November 17, 2014
13:20 EDTCMNCantel Medical names Jorgen Hansen as President, COO
Subscribe for More Information
09:22 EDTINOOn The Fly: Pre-market Movers
Subscribe for More Information
07:16 EDTQMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
05:30 EDTINOInovio, Roche terminate collaboration for INO-5150
Subscribe for More Information
November 16, 2014
13:41 EDTMDCOThe Medicines Co. presents findings from MDCO-216 study
The Medicines Company presented findings from a new Phase 1 study showing that a single infusion of MDCO-216, an investigational lipid-modifying agent, in both healthy and CAD patients, modified key lipid parameters including ApoA-1, phospholipids, HDL, pre-beta 1 HDL and Apo E, markedly increased ABCA1 mediated efflux, a potential marker of reverse cholesterol transport and was well tolerated. The study was presented today as part of a poster session at The American Heart Association’s Annual Scientific Sessions in Chicago. Clinical findings have shown that human carriers of the ApoA-1 Milano variant have a reduced incidence of cardiovascular disease. MDCO-216, currently under development by The Medicines Company, is a complex of recombinant human Apo A1 with phospholipids to emulate an HDL particle. MDCO-216 has the potential to modify atherosclerotic disease by promoting reverse cholesterol transport, and its potential impact on reducing cardiovascular events in acute coronary syndrome, ACS, patients. “This study provides a signal that MDCO-216 is able to modulate lipid parameters consistent with those humans with the ApoA-1 variant, had an important effect on markers of reverse cholesterol transport such as pre-beta1 HDL and ABCA1 mediated efflux, and importantly was well-tolerated,” commented David Kallend, MBBS, Vice President and Global Medical Director for the Lipid Programs at The Medicine Company. “These findings support the continued development of MDCO-216 as a potential treatment to help address a currently unmet need in coronary artery disease patients."
November 14, 2014
11:03 EDTCNATConatus management to meet with Roth Capital
Subscribe for More Information
10:33 EDTMDCOThe Medicines Co. to present new data on MDCO-216 at AHA sessions
Subscribe for More Information
November 12, 2014
16:09 EDTCNATConatus reports Q3 EPS (42c), consensus (44c)
Subscribe for More Information
16:04 EDTTTHITransition Therapeutics reports Q1 EPS (45c), consensus (18c)
08:13 EDTARRYBoston Biotech to hold a conference
Subscribe for More Information
November 10, 2014
16:53 EDTOFIXOrthofix files to delay Form 10-Q
Subscribe for More Information
15:53 EDTQCredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 11 at 10:30 am; not all company presentations may be webcasted. Webcast Link
08:13 EDTOFIXOrthofix initiates first U.S. clinical study of PEMF technology
Subscribe for More Information
07:19 EDTQCredit Suisse to hold a conference
Subscribe for More Information
06:02 EDTINOInovio reports Q3 EPS (12c), consensus (14c)
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use